Correlation Between GlaxoSmithKline PLC and ISS AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and ISS AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and ISS AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and ISS AS, you can compare the effects of market volatilities on GlaxoSmithKline PLC and ISS AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of ISS AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and ISS AS.

Diversification Opportunities for GlaxoSmithKline PLC and ISS AS

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between GlaxoSmithKline and ISS is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and ISS AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ISS AS and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with ISS AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ISS AS has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and ISS AS go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and ISS AS

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the ISS AS. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.02 times less risky than ISS AS. The stock trades about -0.23 of its potential returns per unit of risk. The ISS AS is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest  13,170  in ISS AS on September 1, 2024 and sell it today you would lose (370.00) from holding ISS AS or give up 2.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  ISS AS

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
ISS AS 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ISS AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, ISS AS is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and ISS AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and ISS AS

The main advantage of trading using opposite GlaxoSmithKline PLC and ISS AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, ISS AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ISS AS will offset losses from the drop in ISS AS's long position.
The idea behind GlaxoSmithKline PLC ADR and ISS AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like